These drugs are part of a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists or GLP-1 RAs)
GLP-1 medications themselves are not typically the direct cause of hair loss
It analyzes pathway-level variants in SOD2, GPX1, GSTM1 that shape baseline biology the upstream context that applies across all longevity-protocol compounds
These findings highlight a shift from a baseline inflammatory profile associated with ocular surface damage toward a post-treatment milieu in which cytokine expression parallels improvements in tear production and PROMs
Community protocols on TRT describe: 5-10 mg subcutaneous, 3-5x per week Dosing on training days for synergy with exercise 8-12 week cycles Monitoring fasting glucose and insulin-sensitivity markers For the full protocol, see our MOTS-c dosing guide and MOTS-c results timeline
Like L-Carnitine, Alcar produces energy in the mitochondria of the cell